"CoreWeave (Nasdaq:CRWV) enters earnings day with strong momentum across AI training and a fast-rising inference mix, underpinned by expanding capacity, deepening hyperscaler ties, and a capital program designed for scale. Q2 revenue grew 207% year over year to $1.2 billion with adjusted EBITDA of $753 million and a 62% margin, while contracted backlog reached $30.1 billion. Management says supply remains the binding constraint, not demand."
"Backlog durability and hyperscaler expansions- Backlog stood at $30.1 billion exiting Q2 and management disclosed expansion contracts with both hyperscaler customers around quarter-end. Look for color on sequential backlog and visibility into multiyear commitments. Verticalization strategy and Core Scientific acquisition- CoreWeave argues owning data-center infrastructure can eliminate >$10 billion of future lease liabilities and drive ~$500 million of fully ramped annual run-rate savings by end-2027. Any regulatory, integration, or financing updates will be stock-relevant."
CoreWeave reported Q2 revenue of $1.2 billion, a 207% year-over-year increase, with adjusted EBITDA of $753 million and a 62% margin. Contracted backlog reached $30.1 billion, and management identifies supply limitations, not demand, as the primary constraint. The company continues expanding capacity and deepening hyperscaler relationships while pursuing a capital program to scale operations. The Core Scientific acquisition is positioned to eliminate more than $10 billion of future lease liabilities and deliver roughly $500 million of annual run-rate savings when fully ramped by end-2027. CoreWeave raised $6.4 billion in financing since Q1 to lower borrowing costs.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]